Cytonome has assembled an impressive team for its Board of Directors, comprised of Nobel Prize winning scientists, successful CEOs and representatives from substantial financial institutions.
* Use in patient studies requires compliance with FDA requirements or the requirements of other appropriate national regulatory authorities. Gigasort™ systems have no specificity as to which cells are separated. To separate selected cell types, the user supplies the reagents that provide cell specificity and sets program parameters of the Gigasort™ system to conform to the user's protocol specifications.
